Company intelligence

CTKB

Cytek Biosciences, Inc. · NASDAQ · Healthcare

Price$5.43+1.31% · +$0.07

Market cap701.24MEquity value

P / E-28.8Trailing ratio

Volume3.88MLatest session

Market data

CTKB price chart

TradingView

Related signals

1 min delayed

Browse public CTKB signals with their source context and measured market impact. Open any signal for its permanent analysis page.

CTKBMay 9, 2024-1.12% since signal

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Tops Revenue Estimates

- Cytek Biosciences reported an earnings surprise of 80% and revenue of $44.86 million. - The stock has underperformed the market, losing about 30% since the beginning of the year. - Investors should watch for changes in earnings estimates and industry outlook. Price Impact Rating: bullish Impact Horizon Rating: short-term Type: Earnings

View signal analysis

Research